Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Annesley

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|July 1, 1989
Special considerations for geriatric therapeutic drug monitoringT M Annesley
Mayo Clinic Proceedings|October 1, 1989
Human serum banks: a valuable resource--maybeT M Annesley
Therapeutic Drug Monitoring|August 1, 1994
Determination of felbamate in human serum by high-performance liquid chromatographyT M Annesley, L T Clayton
Medical Laboratory Sciences|January 1, 1989
Bleach and LISS: a potential hazardT M Annesley, W J Judd
The Journal of Biological Chemistry|November 25, 1978
Formation and utilization of novel high energy phosphate reservoirs in Ehrlich ascites tumor cells. Cyclocreatine-3-P and creatine-PT M Annesley, J B Walker
The Journal of Biological Chemistry|May 10, 1980
Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrineT M Annesley, J B Walker
Biochemical and Biophysical Research Communications|January 10, 1977
Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energistic considerationsT M Annesley, J B Walker
American Journal of Clinical Pathology|February 1, 1983
Ectopic creatine kinase MB production in metastatic cancerT M Annesley, B J McKenna
Transfusion Medicine Reviews|April 1, 1996
The acquired-B phenomenonW J Judd, T M Annesley
Therapeutic Drug Monitoring|October 1, 1992
High-performance liquid chromatographic analysis of cyclosporin G (Nva2-cyclosporine) in human bloodT M Annesley, K Matz, A B Leichtman
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|July 1, 1989
Special considerations for geriatric therapeutic drug monitoringT M Annesley
Mayo Clinic Proceedings|October 1, 1989
Human serum banks: a valuable resource--maybeT M Annesley
Therapeutic Drug Monitoring|August 1, 1994
Determination of felbamate in human serum by high-performance liquid chromatographyT M Annesley, L T Clayton
Medical Laboratory Sciences|January 1, 1989
Bleach and LISS: a potential hazardT M Annesley, W J Judd
The Journal of Biological Chemistry|November 25, 1978
Formation and utilization of novel high energy phosphate reservoirs in Ehrlich ascites tumor cells. Cyclocreatine-3-P and creatine-PT M Annesley, J B Walker
The Journal of Biological Chemistry|May 10, 1980
Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrineT M Annesley, J B Walker
Biochemical and Biophysical Research Communications|January 10, 1977
Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Energistic considerationsT M Annesley, J B Walker
American Journal of Clinical Pathology|February 1, 1983
Ectopic creatine kinase MB production in metastatic cancerT M Annesley, B J McKenna
Transfusion Medicine Reviews|April 1, 1996
The acquired-B phenomenonW J Judd, T M Annesley
Therapeutic Drug Monitoring|October 1, 1992
High-performance liquid chromatographic analysis of cyclosporin G (Nva2-cyclosporine) in human bloodT M Annesley, K Matz, A B Leichtman
Pageof 4